We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

The same company's Cervarix—a vaccine comprising human papilloma virus types 16 and 18 in L1 virus-like particles that has been long touted as a competitor for Merck's Gardasil vaccine—finally ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

The first jury trial against Merck’s Gardasil vaccine began Jan. 21 in a state court in Los Angeles. Separately, there is an ongoing federal court case against Merck involving almost 200 ...

Overall, this was a softer quarter. MRK posts encouraging Q4 results. However, the decision to temporarily halt shipments of Gardasil vaccines to China has affected its 2025 sales forecast.

Overall, this was a softer quarter. MRK posts encouraging Q4 results. However, the decision to temporarily halt shipments of Gardasil vaccines to China has affected its 2025 sales forecast.

A landmark study reporting the discovery of Australopithecus africanus one century ago put the African continent at the centre of the story of humanity. Overcrowding can lead to disaster, and yet ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...